{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:57:10Z","timestamp":1791478630065,"version":"4.3.4"},"reference-count":6,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019719","name":"Chiesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"DOI":"10.1080\/03007995.2026.2736356","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:34:12Z","timestamp":1791477252000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Authors\u2019 response to the letter to the editor regarding \u201cCarbon dioxide equivalent emissions and cost impact of non-clinically driven inhaler initiation or switch for COPD\u201d"],"prefix":"10.1080","author":[{"given":"Krishnali","family":"Parsekar","sequence":"first","affiliation":[{"name":"Respiratory and Immunology Health Economics and Payer Evidence, BioPharmaceuticals, AstraZeneca","place":["Cambridge, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Xydopoulos","sequence":"additional","affiliation":[{"name":"ZS Associates LTD, HEOR Practice","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhamid","family":"Yousef","sequence":"additional","affiliation":[{"name":"ZS Associates LTD, HEOR Practice","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Agathangelou","sequence":"additional","affiliation":[{"name":"ZS Associates LTD, HEOR Practice","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Fordham","sequence":"additional","affiliation":[{"name":"Emeritus Professor of Health Economics, University of East Anglia","place":["Norwich, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"K\u00f6ping-H\u00f6gg\u00e5rd","sequence":"additional","affiliation":[{"name":"Market Access, BioPharmaceuticals, AstraZeneca","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Marshall","sequence":"additional","affiliation":[{"name":"Respiratory and Immunology Medical, BioPharmaceuticals R&D, AstraZeneca","place":["Cambridge, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorthe","family":"Petersen","sequence":"additional","affiliation":[{"name":"Medical Affairs, AstraZeneca","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Rustignoli","sequence":"additional","affiliation":[{"name":"UK Market Access Respiratory and Immunology, AstraZeneca","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Soto","sequence":"additional","affiliation":[{"name":"UK Market Access Respiratory and Immunology, AstraZeneca","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bell","sequence":"additional","affiliation":[{"name":"BioPharmaceuticals Medical, AstraZeneca","place":["Cambridge, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Tansey-Dwyer","sequence":"additional","affiliation":[{"name":"Respiratory and Immunology Pricing and Market Access, BioPharmaceuticals, AstraZeneca","place":["Cambridge, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar S.","family":"Usmani","sequence":"additional","affiliation":[{"name":"Imperial College London and Royal Brompton Hospital","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2026.2628120"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2024.209.1_MeetingAbstracts.A2113"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01873-2025"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.2299"},{"key":"e_1_3_2_6_1","unstructured":"Global Initiative for Asthma. GINA Report global strategy for asthma management and prevention. 2026. [cited 2026 Aug 26]. Available from: https:\/\/ginasthma.org\/wp-content\/uploads\/2026\/05\/GINA-2026-Strategy-Report-WMS.pdf."},{"key":"e_1_3_2_7_1","unstructured":"IPCC Global Warming Potential Values. 2024. [cited 2026 Aug 26]. Available from: https:\/\/ghgprotocol.org\/sites\/default\/files\/2024-08\/Global-Warming-Potential-Values%20%28August%202024%29.pdf."}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2026.2736356","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/03007995.2026.2736356","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2026.2736356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:34:13Z","timestamp":1791477253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2026.2736356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":6,"alternative-id":["10.1080\/03007995.2026.2736356"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2026.2736356","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-08-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}